[Form 4] Inspire Veterinary Partners, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Lawrence Alexander, a director of Inspire Veterinary Partners, reported acquiring stock options that give the right to purchase 1,447 shares of Class A Common Stock at an exercise price of $17. The options were recorded with a transaction date of 09/26/2024, are exercisable on 09/26/2024 and expire on 09/26/2034, and are held in a direct ownership form.

The filing notes a corporate action that adjusted reported share counts: the issuer effected a 25-to-1 reverse stock split on 01/27/2025, and the numbers on this Form 4 were updated to reflect that split. The report shows 1,447 options outstanding following the transaction, representing the right to buy 1,447 Class A shares at the stated price until 2034.

Positive

• Director acquisition: Lawrence Alexander acquired 1,447 stock options, signaling insider participation in equity incentives.
• Clear option terms: Options have a specified $17 exercise price, immediate exercisability (09/26/2024) and a defined expiration (09/26/2034), providing transparency.

Negative

• None.

Insights

Securities Analyst

TL;DR: Director received 1,447 options at $17, immediately exercisable, adjusted for a 25:1 reverse split; impact appears limited.

The transaction is an insider option grant recorded as an acquisition of 1,447 derivatives exercisable the same day and expiring in 2034. For investors this is a routine executive compensation event rather than a material capital change: the absolute option count is small and exercise price is explicit at $17. The 25:1 reverse split is a meaningful capital-structure event that affects per-share metrics, but the filing does not disclose other equity changes or large dilution from this grant alone.

Corporate Governance Expert

TL;DR: Immediate exercisability and long expiration window are notable governance details; overall disclosure is straightforward.

The report documents direct beneficial ownership of 1,447 options by a board director with exercisability effective upon grant and a ten-year term, which is consistent with standard equity incentives. The filing also records a 25:1 reverse stock split that required adjustment of reported amounts. No additional governance issues, departures, or related-party terms are disclosed in this filing; the items presented are specific and limited in scope.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lawrence Alexander

(Last) (First) (Middle)

780 LYNNHAVEN PARKWAY

SUITE 400

(Street)

VIRGINIA BEACH VA 23452

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INSPIRE VETERINARY PARTNERS, INC. [ IVP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/26/2024

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$17	09/26/2024		A		1,447		09/26/2024	09/26/2034	Class A Common Stock	1,447	$0	1,447(1)	D

Explanation of Responses:

1. On January 27, 2025, the issuer effected a 25 to 1 reverse stock split of its Class A Common Stock. The number of shares of Class A Common Stock reported on this Form 4 has been adjusted to reflect the reverse stock split.

Remarks:

This Form 4 is being filed late due to inadvertent administrative error.

	/s/ Lawrence Alexander	08/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Lawrence Alexander report on Form 4 for IVP?

He reported acquiring 1,447 stock options exercisable for Class A Common Stock with an exercise price of $17 (transaction date 09/26/2024).

What are the exercisability and expiration dates for the options reported?

The options are exercisable on 09/26/2024 and expire on 09/26/2034.

What is Lawrence Alexander's relationship to Inspire Veterinary Partners (IVP)?

The Form 4 identifies Lawrence Alexander as a Director of Inspire Veterinary Partners, Inc. (ticker: IVP).

Did the company adjust reported share counts, and why?

Yes. The issuer effected a 25-to-1 reverse stock split on 01/27/2025, and the Form 4 figures were adjusted to reflect that split.

How many Class A shares do the options cover?

The derivative securities underlying the grant represent the right to acquire 1,447 shares of Class A Common Stock.

Is ownership direct or indirect according to the filing?

Ownership is reported as Direct (D) for the 1,447 options.